• Mashup Score: 1

    A dedicated curriculum to educate clinicians on the risks associated with severely elevated triglycerides and the potential role of novel treatments to optimize outcomes in patients with sHTG and FCS.

    Tweet Tweets with this article
    • Olezarsen 80mg monthly achieved a statistically significant 32% reduction in triglyceride levels from baseline at 6 months compared to placebo (that sustained at 12 months), per the phase III BALANCE study. Learn the latest ➡️ https://t.co/ORaMVy5DTp https://t.co/jKaaeXzBhK

  • Mashup Score: 1
    Home - 1 month(s) ago

    Activity Overview

    Tweet Tweets with this article
    • 🫀 Learn how to assess residual CV risk in patients with dyslipidemia and explore the latest on CETP inhibition for LDL-C lowering and ASCVD risk reduction. 📍 https://t.co/A4kdNKvOoT #Cardiology #Dyslipidemia #HeartHealth https://t.co/RufGggiOmF